In the first quarter of 2025, U.S. digital health companies raised $3 billion across 122 deals, signaling a rise in overall capital investment even as deal volume remained relatively flat. This led to a significant increase in average deal size—from $15.5 million in the previous quarter to $24.4 million. Early-stage startups continued to dominate the landscape, with Seed, Series A, and Series B rounds making up 83% of all labeled deals. Despite the early-stage focus, a few standout rounds—such as Achira’s $33 million seed, Open Evidence’s $75 million Series A, and Hippocratic AI’s $141 million Series B—highlighted growing confidence in select high-potential players.
The quarter also marked the return of major late-stage investments. While only five Series D or later rounds were tracked, three topped $100 million: Innovaccer at $275 million, Abridge at $250 million, and Qventus at $105 million. These megadeals helped push the overall funding total upward and suggest that investor appetite is still strong for mature companies with clear value propositions. Hippocratic AI, in particular, stood out among the early-stage cohort, reinforcing its rising influence in the AI-driven health care space and building on its momentum from previous quarters.
Read the full article here.